Bottom line
Is VFMFX a good fund? The bottom line
VFMFX is an actively managed large blend mutual fund from Vanguard.
Its expense ratio is 0.18% — about $18 a year on every $10,000 invested, cheaper than 94% of large blend funds we track.
It returned +15.1% over one year, +14.4% a year over five years (as of Dec 31, 2025, per its prospectus).
With $277 million in net assets and 581 holdings, its largest position is Micron Technology Inc (1.4%) and the top 10 make up 8.8% of the portfolio.
What stands out
- Low cost: cheaper than 94% of large blend peers
- 5-year return beat 87% of category peers
- Broadly diversified (581 holdings)
- No front-end sales load
Updated Nov 19, 2026
What VFMFX invests in
Vanguard U.S. Multifactor Fund (the Fund) seeks to provide long-term capital appreciation by investing in stocks with relatively strong recent performance, strong fundamentals, and low prices relative to fundamentals as determined by the advisor.
The Fund employs an active management approach, investing primarily in U.S. common stocks with the potential to generate higher returns relative to the broad U.S. equity market by selecting stocks with relatively strong recent performance, strong fundamentals, and low prices relative to fundamentals as determined by the advisor. The Funds portfolio includes a diverse mix of companies representing many different market sectors and industry groups. The advisor uses a quantitative model to evaluate all of the securities in an investment universe comprised of U.S. large-, mid-, and small-capitalization stocks and to construct a U.S. equity portfolio that seeks to achieve exposure to multiple factors subject to a rules-based screen designed to promote diversification and to mitigate exposure to certain less liquid and more volatile stocks. Under normal circumstances, the Fund invests at…
From the fund's prospectus (filed Mar 27, 2026).
VFMFX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| VFMFX | +15.1% | +14.4% | — |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What VFMFX costs
On a $10,000 investment, VFMFX's 0.18% expense ratio costs about $18 a year. The prospectus estimates $230 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
VFMFX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Micron Technology Inc | 1.36% |
| 2 | Bank of New York Mellon Corp/The | 0.95% |
| 3 | Cisco Systems Inc | 0.91% |
| 4 | Lam Research Corp | 0.85% |
| 5 | Bristol-Myers Squibb Co | 0.83% |
| 6 | Newmont Corp | 0.82% |
| 7 | CVS Health Corp | 0.80% |
| 8 | EOG Resources Inc | 0.78% |
| 9 | Amgen Inc | 0.76% |
| 10 | Altria Group Inc | 0.74% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 8.8% of the fund. See all top 25 holdings and asset mix →